Stock Track | Danaher Plummets 5.03% Intraday After Q1 Revenue Miss and Multiple Analyst Price Target Cuts

Stock Track04-23

Danaher Corporation's stock plummeted 5.03% during intraday trading on Wednesday. The sharp decline followed the life sciences company's first-quarter financial results, which revealed a revenue miss against market expectations.

The company reported earnings that beat estimates, but revenue fell short of consensus forecasts. This rare organic revenue miss was attributed partly to weaker demand for flu and respiratory testing. In response to the mixed quarterly performance, several prominent Wall Street firms, including TD Cowen, UBS, Wells Fargo, Morgan Stanley, and Guggenheim, cut their price targets on Danaher's stock.

While some analysts noted early signs of recovery in certain segments like bioprocessing equipment orders and China demand, the immediate market reaction was dominated by concerns over the revenue shortfall and the subsequent downward revisions in analyst targets, driving the stock's significant intraday drop.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1100451940?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-23 03:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1100451940","market":"sg","top_or_hot":-1,"title":"Stock Track | Danaher Plummets 5.03% Intraday After Q1 Revenue Miss and Multiple Analyst Price Target Cuts","media":"Stock Track","content":"<p>Danaher Corporation's stock plummeted 5.03% during intraday trading on Wednesday. The sharp decline followed the life sciences company's first-quarter financial results, which revealed a revenue miss against market expectations.</p><p>The company reported earnings that beat estimates, but revenue fell short of consensus forecasts. This rare organic revenue miss was attributed partly to weaker demand for flu and respiratory testing. In response to the mixed quarterly performance, several prominent Wall Street firms, including TD Cowen, UBS, Wells Fargo, Morgan Stanley, and Guggenheim, cut their price targets on Danaher's stock.</p><p>While some analysts noted early signs of recovery in certain segments like bioprocessing equipment orders and China demand, the immediate market reaction was dominated by concerns over the revenue shortfall and the subsequent downward revisions in analyst targets, driving the stock's significant intraday drop.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Danaher Plummets 5.03% Intraday After Q1 Revenue Miss and Multiple Analyst Price Target Cuts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Danaher Plummets 5.03% Intraday After Q1 Revenue Miss and Multiple Analyst Price Target Cuts\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-04-23 03:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Danaher Corporation's stock plummeted 5.03% during intraday trading on Wednesday. The sharp decline followed the life sciences company's first-quarter financial results, which revealed a revenue miss against market expectations.</p><p>The company reported earnings that beat estimates, but revenue fell short of consensus forecasts. This rare organic revenue miss was attributed partly to weaker demand for flu and respiratory testing. In response to the mixed quarterly performance, several prominent Wall Street firms, including TD Cowen, UBS, Wells Fargo, Morgan Stanley, and Guggenheim, cut their price targets on Danaher's stock.</p><p>While some analysts noted early signs of recovery in certain segments like bioprocessing equipment orders and China demand, the immediate market reaction was dominated by concerns over the revenue shortfall and the subsequent downward revisions in analyst targets, driving the stock's significant intraday drop.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DHR","symbol_name":"丹纳赫","start_time":0,"source_url":"","article_id":"1100451940","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1100451940","pubTimestamp":1776885420,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Danaher Corporation's stock plummeted 5.03% during intraday trading on Wednesday. The sharp decline followed the life sciences company's first-quarter financial results, which revealed a revenue miss...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"DHR":"丹纳赫"},"translate_title":"个股追踪|Q1营收未达预期且多位分析师下调目标价丹纳赫盘中暴跌5.03%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DHR":1},"content_text":"Danaher Corporation's stock plummeted 5.03% during intraday trading on Wednesday. The sharp decline followed the life sciences company's first-quarter financial results, which revealed a revenue miss against market expectations.The company reported earnings that beat estimates, but revenue fell short of consensus forecasts. This rare organic revenue miss was attributed partly to weaker demand for flu and respiratory testing. In response to the mixed quarterly performance, several prominent Wall Street firms, including TD Cowen, UBS, Wells Fargo, Morgan Stanley, and Guggenheim, cut their price targets on Danaher's stock.While some analysts noted early signs of recovery in certain segments like bioprocessing equipment orders and China demand, the immediate market reaction was dominated by concerns over the revenue shortfall and the subsequent downward revisions in analyst targets, driving the stock's significant intraday drop.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1100451940","isCrawlerRequest":true}